Elevance Health, Inc. (ELV) — SEC Filings

Latest SEC filings for Elevance Health, Inc. (ELV), explained in plain English.

Sentiment Overview: 1 bullish, 32 neutral, 1 mixed

Recent Filings (34)

• Elevance Health Reports Director, Officer, and Compensation Changes — 8-K · 2025-12-10T00:00:00.000Z [neutral] Risk: low
  Elevance Health, Inc. filed an 8-K on December 10, 2025, reporting changes related to its board of directors and officers, including the election of new directo
• 8-K Filing — 8-K · 2025-11-10T00:00:00.000Z [neutral]
• Elevance Health Files 8-K on Financials — 8-K · 2025-10-21T00:00:00.000Z [neutral] Risk: low
  Elevance Health, Inc. filed an 8-K on October 21, 2025, reporting on its results of operations and financial condition. The filing includes financial statements
• Elevance Health Q3 Revenue Jumps, But YTD Net Income Dips — 10-Q · 2025-10-21T00:00:00.000Z [mixed] Risk: medium
  Elevance Health, Inc. reported total revenues of $50,711 million for the three months ended September 30, 2025, an increase from $45,106 million in the prior ye
• Elevance Health Files 8-K — 8-K · 2025-09-15T00:00:00.000Z [neutral] Risk: low
  Elevance Health, Inc. filed an 8-K on September 15, 2025, reporting an event that occurred on September 8, 2025. The filing indicates "Other Events" and "Financ
• Elevance Health Files 8-K for Regulation FD Disclosure — 8-K · 2025-09-04T00:00:00.000Z [neutral] Risk: low
  Elevance Health, Inc. filed an 8-K on September 4, 2025, to report a Regulation FD Disclosure. The filing does not contain specific financial figures or new mat
• Elevance Health Announces Board and Executive Compensation Changes — 8-K · 2025-07-28T00:00:00.000Z [neutral] Risk: low
  Elevance Health, Inc. announced on July 28, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of
• Elevance Health Q2 Revenue Jumps to $45.2B, Net Income Up 10.5% — 10-Q · 2025-07-17T00:00:00.000Z [bullish] Risk: medium
  Elevance Health, Inc. reported robust financial performance for the second quarter ended June 30, 2025, with total revenues reaching $45.2 billion, a significan
• Elevance Health Files 8-K for Regulation FD Disclosure — 8-K · 2025-05-28T00:00:00.000Z [neutral] Risk: low
  Elevance Health, Inc. filed an 8-K on May 28, 2025, to report a Regulation FD Disclosure. The filing does not contain specific financial figures or new material
• Elevance Health Files 8-K on Shareholder Votes — 8-K · 2025-05-14T00:00:00.000Z [neutral] Risk: low
  Elevance Health, Inc. filed an 8-K on May 14, 2025, to report on matters submitted to a vote of its security holders. The filing indicates that the company held
• Elevance Health Files Q1 2025 10-Q — 10-Q · 2025-04-22T00:00:00.000Z [neutral] Risk: low
  Elevance Health, Inc. filed its 10-Q for the period ending March 31, 2025. The filing covers the first quarter of 2025 and provides financial details for the co
• Elevance Health Files 8-K on Operations & Financials — 8-K · 2025-04-17T00:00:00.000Z [neutral] Risk: low
  Elevance Health, Inc. filed an 8-K on April 17, 2025, to report on its results of operations and financial condition, as well as a Regulation FD disclosure. The
• Elevance Health Executive Compensation Details Revealed — DEF 14A · 2025-03-28T00:00:00.000Z [neutral] Risk: low
  Elevance Health, Inc. filed its DEF 14A on March 28, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes in
• Elevance Health Files 8-K for Regulation FD Disclosure — 8-K · 2025-03-10T00:00:00.000Z [neutral] Risk: medium
  Elevance Health, Inc. filed an 8-K on March 10, 2025, to report a Regulation FD Disclosure. The filing does not contain specific details about the nature of the
• Elevance Health Files 2024 10-K — 10-K · 2025-02-20T00:00:00.000Z [neutral] Risk: low
  Elevance Health, Inc. filed its 2024 10-K on February 20, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company, f
• Elevance Health Files 8-K on Financials — 8-K · 2025-01-23T00:00:00.000Z [neutral] Risk: low
  Elevance Health, Inc. filed an 8-K on January 23, 2025, reporting on its results of operations and financial condition. The filing includes financial statements
• SC 13G/A Filing — SC 13G/A · 2024-11-14T00:00:00.000Z [neutral]
• Elevance Health Files 8-K — 8-K · 2024-10-31T00:00:00.000Z [neutral] Risk: low
  Elevance Health, Inc. filed an 8-K on October 31, 2024, reporting an event that occurred on October 22, 2024. The filing primarily concerns financial statements
• Elevance Health Q3 2024 10-Q Filing — 10-Q · 2024-10-17T00:00:00.000Z [neutral] Risk: low
  Elevance Health, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported financial results for the third quarter and the first nine m
• Elevance Health Files Q2 2024 10-Q — 10-Q · 2024-07-17T00:00:00.000Z [neutral] Risk: low
  Elevance Health, Inc. filed its 10-Q for the period ending June 30, 2024, reporting on its financial performance. The company, formerly known as Anthem, Inc., i
• Elevance Health Files 8-K — 8-K · 2024-06-12T00:00:00.000Z [neutral] Risk: low
  Elevance Health, Inc. filed an 8-K on June 12, 2024, to report information under Regulation FD. The filing does not contain specific financial figures or materi
• Elevance Health Files 8-K — 8-K · 2024-05-30T00:00:00.000Z [neutral] Risk: low
  Elevance Health, Inc. filed an 8-K on May 30, 2024, reporting an event that occurred on May 20, 2024. The filing pertains to "Other Events" and "Financial State
• Elevance Health Files 8-K on Shareholder Votes — 8-K · 2024-05-15T00:00:00.000Z [neutral] Risk: low
  Elevance Health, Inc. filed an 8-K on May 15, 2024, to report on matters submitted to a vote of its security holders. The filing indicates that the company held
• Elevance Health Proxy Filing Details Executive Compensation — DEFA14A · 2024-04-22T00:00:00.000Z [neutral] Risk: low
  Elevance Health, Inc. (formerly Anthem, Inc.) filed a DEFA14A, indicating a Definitive Proxy Statement. This filing details executive compensation and related m
• Elevance Health Files 8-K on Financials — 8-K · 2024-04-18T00:00:00.000Z [neutral] Risk: low
  Elevance Health, Inc. filed an 8-K on April 18, 2024, reporting on its results of operations and financial condition. The filing includes financial statements a
• Elevance Health Q1 2024 10-Q Filing — 10-Q · 2024-04-18T00:00:00.000Z [neutral] Risk: low
  Elevance Health, Inc. filed its 10-Q for the period ending March 31, 2024. The filing details financial performance and operational updates for the first quarte
• Elevance Health Files 2023 DEF 14A — DEF 14A · 2024-03-29T00:00:00.000Z [neutral] Risk: low
  Elevance Health, Inc. filed its DEF 14A on March 29, 2024, detailing executive compensation and corporate governance matters for the fiscal year ending December
• Elevance Health Files 8-K — 8-K · 2024-03-04T00:00:00.000Z [neutral] Risk: low
  Elevance Health, Inc. filed an 8-K on March 4, 2024, to disclose information under Regulation FD. The filing does not contain specific financial figures or mate
• Elevance Health Files 2023 10-K, Details Financials — 10-K · 2024-02-21T00:00:00.000Z [neutral] Risk: medium
  Elevance Health, Inc. filed its 10-K on February 21, 2024, for the fiscal year ended December 31, 2023. The company, formerly known as Anthem, Inc. and WELLPOIN
• SC 13G Filing — SC 13G · 2024-02-14T00:00:00.000Z [neutral]
• SC 13G/A Filing — SC 13G/A · 2024-02-13T00:00:00.000Z [neutral]
• BlackRock Updates Elevance Health Stake in SC 13G/A Filing — SC 13G/A · 2024-02-12T00:00:00.000Z [neutral] Risk: low
  BlackRock Inc. filed an amended SC 13G/A on February 12, 2024, indicating its ownership of Elevance Health, Inc. (formerly Anthem, Inc.) common stock as of Dece
• Elevance Health Files Routine 8-K on Jan 25, No Major News — 8-K · 2024-01-25T00:00:00.000Z [neutral]
  Elevance Health, Inc. filed an 8-K on January 25, 2024, reporting an "Other Event" that occurred on January 23, 2024. This filing is a routine disclosure, prima
• Elevance Health Files 8-K on Financial Condition, Operations — 8-K · 2024-01-24T00:00:00.000Z [neutral]
  Elevance Health, Inc. filed an 8-K on January 24, 2024, to report its results of operations and financial condition, along with financial statements and exhibit